Mesoblast Limited Cash Flow-to-Debt Ratio
Mesoblast Limited cash flow-to-debt ratio. Mesoblast Limited (LWB) has a Cash Flow-to-Debt Ratio of -0.10x as of June 2023, meaning its operating cash flow of €-16.28 Million could theoretically repay 0% of its total liabilities (€167.58 Million) in one year. Check Mesoblast Limited cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Mesoblast Limited (2014–2025)
Cash flow-to-debt ratio of Mesoblast Limited from 2014 to 2025. Historical debt coverage capacity for Mesoblast Limited across 12 annual periods. Check how aggressively does Mesoblast Limited reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Mesoblast Limited Cash Flow-to-Debt Ratio by Year (2014–2025)
Mesoblast Limited cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Mesoblast Limited. For the full cash flow conversion analysis, see LWB cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.27x | €-49.95 Million | €187.24 Million | ▼ -3.9% |
| 2024 | -0.26x | €-48.46 Million | €188.80 Million | ▲ +32.0% |
| 2023 | -0.38x | €-63.27 Million | €167.58 Million | ▲ +5.2% |
| 2022 | -0.40x | €-65.78 Million | €165.10 Million | ▲ +35.4% |
| 2021 | -0.62x | €-100.75 Million | €163.32 Million | ▼ -101.7% |
| 2020 | -0.31x | €-56.37 Million | €184.28 Million | ▲ +9.5% |
| 2019 | -0.34x | €-57.79 Million | €171.06 Million | ▲ +34.1% |
| 2018 | -0.51x | €-75.01 Million | €146.44 Million | ▲ +25.5% |
| 2017 | -0.69x | €-95.47 Million | €138.92 Million | ▼ -21.7% |
| 2016 | -0.56x | €-88.00 Million | €155.86 Million | ▼ -75.3% |
| 2015 | -0.32x | €-101.04 Million | €313.78 Million | ▼ -32.8% |
| 2014 | -0.24x | €-74.91 Million | €308.95 Million | — |